C

CatalYm GmbH

32 employees

CatalYm is a biotechnology company developing innovative immunotherapies for cancer patients.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Medical

Date founded

2016

Funding rounds raised

Total raised

$59M

from 13 investors over 13 rounds

C

CatalYm GmbH raised $51M on November 22, 2022

Investors: Brandon Capital Partners, coparion, JEITO, Vesalius Biocapital, BGV (BioGeneration Ventures), Forbion and Bayern Kapital GmbH

C

CatalYm GmbH raised $59M on November 19, 2020

Investors: coparion, BGV (BioGeneration Ventures), Vesalius Biocapital, Forbion and StMWi

C

CatalYm GmbH raised undisclosed on August 5, 2016

Investors: Forbion

FAQ